Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 82
Selected: 0
NCT IDTitle
NCT01271387Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
NCT04353401WGS Analysis of COVID-19 Positive Patients
NCT00467441VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
NCT02180451Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
NCT04127058Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
NCT04712734A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
NCT03772340Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
NCT02004041Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
NCT05903924Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT07223632Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
NCT01430754Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
NCT04800237Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
NCT00548340VEC-162 Study in Adult Patients With Primary Insomnia
NCT01218789Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
NCT04697056A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
NCT04856917A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris
NCT00490945Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
NCT03291041A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
NCT06830044Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
NCT01540500Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
NCT01495169Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
NCT02621385Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
NCT04652882Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
NCT04697069A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
NCT05344365A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
NCT02413918Iloperidone in Mixed States of Bipolar Disorder
NCT04140695Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
NCT06803290Food Effect Study of VHX-896 in Healthy Volunteers
NCT07065773Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
NCT02231008Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
NCT04849559Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
NCT01428661Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
NCT01402076A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
NCT01348100Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients
NCT01919944Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P
NCT01429116Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
NCT05361707Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
NCT01637636Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.
NCT06701396Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
NCT06804603A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
NCT07090161Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
NCT02970968Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
NCT05922995The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
NCT06961968Randomized Withdrawal Study in Patients With Schizophrenia
NCT04327661Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
NCT00291187VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
NCT01163032Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
NCT01578057Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
NCT06836557Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
NCT04819776Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder